New data reveals that retatrutide, a novel medication, might represent a significant step in weight reduction . This therapy combines the effects of a GLP-1 receptor and a GIP receptor , potentially offering a greater impact than existing therapies . Clinical assessments have revealed positive findings , including considerable decreases in size an